Biolinerx Ltd. balance sheet

At the end of fiscal 2025, Biolinerx Ltd. had total assets of $40.9m, total liabilities of $17.6m and shareholders' equity of $18.2m. It held $3.3m in cash against $0 of debt: net cash of $3.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Biolinerx Ltd.: balance sheet, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	13	11	4	10	3
Inventory	—	0	2	3	2
Total current assets	57	52	47	27	24
Total assets	81	76	64	39	41
Total current liabilities	10	11	43	15	12
Total debt	—	0	0	0	0
Total liabilities	13	26	51	25	18
Shareholders' equity	68	51	13	13	18
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	5
Net debt (negative = net cash)	−13	−11	−4	−10	−3

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BLRX vs LGVN BLRX vs DARE BLRX vs STTK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biolinerx Ltd.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biolinerx Ltd.